ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תרחיף - voriconazole 40 mg/ml - voriconazole - voriconazole - treatment of : invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) , serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - קפסולה קשיחה - isavuconazole as sulfate 100 mg - isavuconazole

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - אבקה להכנת תמיסה מרוכזת לעירוי - isavuconazole as sulfate 200 mg - isavuconazole